Carillon Tower Advisers’s Certara CERT Stock Holding History

Carillon Tower Advisers’s Portfolio CERT Stock Details CERT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$13.3M	Buy	+394,274	New	+$14.4M	0.08%	306

Other funds holding CERT

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHMI

Howard Hughes Medical Institute Chevy Chase, Maryland $445M AUM 42.75% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Carillon Tower Advisers's CERT Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in Certara (CERT) in Q4 2020: 394,274 shares worth $13.3M. The stake represents 0.08% of the portfolio and ranks #306 among its holdings.

100 funds tracked by Wall St. Rank hold CERT as of Q4 2020.

Carillon Tower Advisers held 394,274 shares of Certara worth $13.3M as of Q4 2020.
Certara was a new Carillon Tower Advisers position in Q4 2020.
Certara made up 0.08% of Carillon Tower Advisers's portfolio in Q4 2020, its #306 holding.
100 funds tracked by Wall St. Rank held Certara as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.